acetaminophen has been researched along with scopolamine hydrobromide in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.52) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 7 (33.33) | 29.6817 |
| 2010's | 10 (47.62) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Alimuddin, M; Bulloch, D; Dahl, R; Grant, D; Lee, N; Peacock, M | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| McMartin, C; Street, HV | 1 |
| Cintrón, NM; Putcha, L | 1 |
| Putcha, L | 1 |
| HARRIS, LE; POGGE, RC | 1 |
| Del Vecchio, RA; Hyde, LA; Kazdoba, TM | 1 |
| Ortiz, MI | 1 |
| Lee, G; Mundstock, A | 1 |
| Nakama-Kitamura, M | 1 |
| Cunha, RR; Muñoz, RAA; Ribeiro, MMAC; Richter, EM | 1 |
| Aleshi, P; Chiu, C; Esserman, LJ; Harbell, MW; Inglis-Arkell, C; Whitlock, EL; Yap, E | 1 |
1 review(s) available for acetaminophen and scopolamine hydrobromide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
20 other study(ies) available for acetaminophen and scopolamine hydrobromide
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Determination of log D via automated microfluidic liquid-liquid extraction.
Topics: Automation; Biopharmaceutics; Microfluidic Analytical Techniques; Pharmacokinetics | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Gas-liquid chromatography of submicrogram amounts of drugs. I. Preparation, scope and limitation of columns.
Topics: Acetaminophen; Amphetamine; Caffeine; Chlordiazepoxide; Chromatography, Gas; Cyclizine; Morphine; Phenelzine; Phenylbutazone; Salicylates; Scopolamine; Secobarbital; Trifluoperazine | 1966 |
Pharmacokinetic consequences of spaceflight.
Topics: Acetaminophen; Bed Rest; Biological Availability; Dextroamphetamine; Humans; Saliva; Scopolamine; Space Flight; Time Factors; Weightlessness | 1991 |
Pharmacotherapeutics in space.
Topics: Acetaminophen; Aerospace Medicine; Analgesics, Non-Narcotic; Headache; Histamine H1 Antagonists; Humans; Muscarinic Antagonists; Pharmacology, Clinical; Promethazine; Saliva; Scopolamine; Space Flight; Space Motion Sickness; Weightlessness | 1999 |
TIMED-RELEASE TABLETS: DEMONSTRATION OF MECHANISM IN HUMAN SUBJECTS.
Topics: Acetaminophen; Analgesics; Analgesics, Non-Narcotic; Anti-Allergic Agents; Antipyretics; Antitussive Agents; Biomedical Research; Delayed-Action Preparations; Histamine H1 Antagonists; Hydrocortisone; Pheniramine; Phenylpropanolamine; Scopolamine; Sympathomimetics; Tablets | 1964 |
Automated evaluation of sensitivity to foot shock in mice: inbred strain differences and pharmacological validation.
Topics: Acetaminophen; Acoustic Stimulation; Analgesics; Analgesics, Non-Narcotic; Animals; Anti-Anxiety Agents; Behavior, Animal; Diazepam; Efferent Pathways; Electroshock; Fear; Mice; Mice, Inbred Strains; Muscarinic Antagonists; Neural Pathways; Pain Measurement; Reflex, Startle; Scopolamine; Species Specificity | 2007 |
Primary dysmenorrhea among Mexican university students: prevalence, impact and treatment.
Topics: Absenteeism; Acetaminophen; Adolescent; Dipyrone; Drug Combinations; Dysmenorrhea; Female; Humans; Menarche; Mexico; Naproxen; Nonprescription Drugs; Pain; Prevalence; Propanolamines; Pyrilamine; Scopolamine; Severity of Illness Index; Students; Theophylline; Universities; Young Adult | 2010 |
Saturation solubility of nicotine, scopolamine and paracetamol in model stratum corneum lipid matrices.
Topics: Acetaminophen; Epidermis; Lipids; Microscopy; Nicotine; Scattering, Small Angle; Scopolamine; Solubility; X-Ray Diffraction | 2014 |
The distinctive significance of analgesic drugs and olfactory stimulants on learned pain in mice.
Topics: Acetaminophen; Amines; Analgesics; Animals; Conditioning, Psychological; Cyclohexanecarboxylic Acids; Fentanyl; Fluvoxamine; Formaldehyde; Gabapentin; gamma-Aminobutyric Acid; Male; Mice; Motor Activity; Muscarinic Antagonists; Nociceptive Pain; Odorants; Olfactory Perception; Pain Perception; Physical Stimulation; Scopolamine; Selective Serotonin Reuptake Inhibitors | 2014 |
Fast determination of codeine, orphenadrine, promethazine, scopolamine, tramadol, and paracetamol in pharmaceutical formulations by capillary electrophoresis.
Topics: Acetaminophen; Codeine; Drug Compounding; Electrophoresis, Capillary; Orphenadrine; Promethazine; Scopolamine; Tramadol | 2017 |
Improved analgesia and reduced post-operative nausea and vomiting after implementation of an enhanced recovery after surgery (ERAS) pathway for total mastectomy.
Topics: Acetaminophen; Analgesia; Analgesics; Analgesics, Non-Narcotic; Anesthesia, Conduction; Antiemetics; Dexamethasone; Female; Gabapentin; Humans; Intraoperative Care; Length of Stay; Mastectomy, Simple; Middle Aged; Ondansetron; Pain Management; Postoperative Nausea and Vomiting; Preoperative Care; Retrospective Studies; Scopolamine | 2018 |